share_log

Shareholders in Scotts Miracle-Gro (NYSE:SMG) Are in the Red If They Invested Three Years Ago

Shareholders in Scotts Miracle-Gro (NYSE:SMG) Are in the Red If They Invested Three Years Ago

如果三年前進行投資,Scotts Miracle-Gro(紐約證券交易所代碼:SMG)的股東將處於虧損狀態
Simply Wall St ·  02/14 19:44

As an investor, mistakes are inevitable. But you have a problem if you face massive losses more than once in a while. So take a moment to sympathize with the long term shareholders of The Scotts Miracle-Gro Company (NYSE:SMG), who have seen the share price tank a massive 76% over a three year period. That would be a disturbing experience. And more recent buyers are having a tough time too, with a drop of 32% in the last year.

作爲投資者,錯誤是不可避免的。但是,如果你不止一次地面臨巨額損失,你就會遇到問題。因此,花點時間同情Scotts Miracle-Gro公司(紐約證券交易所代碼:SMG)的長期股東,他們的股價在三年內大幅下跌了76%。那將是一次令人不安的經歷。最近的買家也遇到了艱難時期,去年下降了32%。

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

由於從長遠來看,股東會下跌,讓我們來看看那段時間的潛在基本面,看看它們與回報是否一致。

Given that Scotts Miracle-Gro didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

鑑於Scotts Miracle-Gro在過去十二個月中沒有盈利,我們將專注於收入增長,以快速了解其業務發展。無利可圖的公司的股東通常期望強勁的收入增長。這是因爲快速的收入增長可以很容易地推斷出來預測利潤,通常規模相當大。

In the last three years Scotts Miracle-Gro saw its revenue shrink by 13% per year. That's not what investors generally want to see. The share price fall of 21% (per year, over three years) is a stern reminder that money-losing companies are expected to grow revenue. We're generally averse to companies with declining revenues, but we're not alone in that. There's no more than a snowball's chance in hell that share price will head back to its old highs, in the short term.

在過去的三年中,Scotts Miracle-Gro的收入每年減少13%。這不是投資者普遍希望看到的。股價下跌21%(在三年內每年下跌)嚴厲地提醒人們,虧損公司有望增加收入。我們普遍反對收入下降的公司,但我們並不是唯一一個這樣做的公司。在短期內,股價重回原有高點的可能性不大。

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

您可以在下面看到收入和收入如何隨着時間的推移而變化(點擊圖片了解確切的值)。

earnings-and-revenue-growth
NYSE:SMG Earnings and Revenue Growth February 14th 2024
紐約證券交易所:SMG收益和收入增長 2024年2月14日

If you are thinking of buying or selling Scotts Miracle-Gro stock, you should check out this FREE detailed report on its balance sheet.

如果你想買入或賣出Scotts Miracle-Gro的股票,你應該看看這份關於其資產負債表的免費詳細報告。

What About Dividends?

分紅呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Scotts Miracle-Gro's TSR for the last 3 years was -74%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

除了衡量股價回報率外,投資者還應考慮股東總回報率(TSR)。股東總回報率是一種回報計算方法,它考慮了現金分紅的價值(假設收到的任何股息都經過再投資)以及任何貼現資本籌集和分拆的計算價值。因此,對於支付豐厚股息的公司來說,股東總回報率通常遠高於股價回報率。碰巧的是,Scotts Miracle-Gro在過去三年的股東總回報率爲-74%,超過了前面提到的股價回報率。而且,猜測股息支付在很大程度上解釋了這種分歧是沒有好處的!

A Different Perspective

不同的視角

Scotts Miracle-Gro shareholders are down 29% for the year (even including dividends), but the market itself is up 19%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 4% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with Scotts Miracle-Gro (at least 1 which is concerning) , and understanding them should be part of your investment process.

斯科特的Miracle-Gro股東今年下跌了29%(甚至包括股息),但市場本身卻上漲了19%。即使是優質股票的股價有時也會下跌,但我們希望在過於感興趣之前看到企業基本指標的改善。不幸的是,去年的表現可能預示着尚未解決的挑戰,因爲它比過去五年中4%的年化虧損還要糟糕。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。我發現將長期股價視爲業務績效的代表非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。例如,投資風險的幽靈無處不在。我們已經在Scotts Miracle-Gro上發現了3個警告信號(至少有1個令人擔憂),了解它們應該是你投資過程的一部分。

We will like Scotts Miracle-Gro better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些重大的內幕收購,我們會更喜歡Scotts Miracle-Gro。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論